Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bing Z Carter

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Cancer Research|January 25, 2019
An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AMLBing Z Carter, Po Yee Mak, Xiangmeng Wang, et al.
Blood|November 10, 2009
Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AMLBing Z Carter, Duncan H Mak, Wendy D Schober, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2020
A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cellsBailin He, Qiang Wang, Xiaoli Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Therapeutic Molecular Targetingof 15-Lipoxygenase-1 in Colon CancerYuanqing Wu, Bingliang Fang, Xiulan Q Yang, et al.
Experimental Hematology & Oncology|April 17, 2022
Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathwaysQinwei Chen, Suqi Deng, Manman Deng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancerYuanqing Wu, Bingliang Fang, Xiulan Q Yang, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 13, 2010
XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38- cells in a phase 1/2 study of patients with relapsed/refractory AMLBing Z Carter, Duncan H Mak, Stephen J Morris, et al.
Blood|January 12, 2008
Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5Bing Z Carter, Duncan H Mak, Wendy D Schober, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Loss of expression of both miR-15/16 loci in CML transition to blast crisisFrancesca Lovat, Pierluigi Gasparini, Giovanni Nigita, et al.
Cell Cycle (Georgetown, Tex.)|September 14, 2006
Regulation and targeting of Eg5, a mitotic motor protein in blast crisis CML: overcoming imatinib resistanceBing Z Carter, Duncan H Mak, Yuexi Shi, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Cancer Research|January 25, 2019
An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AMLBing Z Carter, Po Yee Mak, Xiangmeng Wang, et al.
Blood|November 10, 2009
Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AMLBing Z Carter, Duncan H Mak, Wendy D Schober, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2020
A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cellsBailin He, Qiang Wang, Xiaoli Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Therapeutic Molecular Targetingof 15-Lipoxygenase-1 in Colon CancerYuanqing Wu, Bingliang Fang, Xiulan Q Yang, et al.
Experimental Hematology & Oncology|April 17, 2022
Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathwaysQinwei Chen, Suqi Deng, Manman Deng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancerYuanqing Wu, Bingliang Fang, Xiulan Q Yang, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 13, 2010
XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38- cells in a phase 1/2 study of patients with relapsed/refractory AMLBing Z Carter, Duncan H Mak, Stephen J Morris, et al.
Blood|January 12, 2008
Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5Bing Z Carter, Duncan H Mak, Wendy D Schober, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Loss of expression of both miR-15/16 loci in CML transition to blast crisisFrancesca Lovat, Pierluigi Gasparini, Giovanni Nigita, et al.
Cell Cycle (Georgetown, Tex.)|September 14, 2006
Regulation and targeting of Eg5, a mitotic motor protein in blast crisis CML: overcoming imatinib resistanceBing Z Carter, Duncan H Mak, Yuexi Shi, et al.
Pageof 8